High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
About the speaker
Roskilde University Hospital, Roskilde (Denmark)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
You may be interested in
Congress Session
Congress Session
Congress Session
